Saba Capital Management, L.P. - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 39 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$2,713,000
+1.2%
270,7510.0%0.03%0.0%
Q2 2022$2,680,000
+0.4%
270,7510.0%0.03%
-18.4%
Q1 2022$2,670,000
+384.6%
270,751
+379.6%
0.04%
+375.0%
Q4 2021$551,000
+109.5%
56,451
+110.1%
0.01%
+33.3%
Q3 2021$263,00026,8740.01%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,008,0001.47%
683 Capital Management, LLC 600,000$6,012,0000.46%
CVI Holdings, LLC 367,552$3,687,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,004,0000.26%
SkyView Investment Advisors, LLC 71,773$719,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,999$10,020,0000.20%
GLAZER CAPITAL, LLC 1,022,411$10,245,0000.19%
METEORA CAPITAL, LLC 56,076$562,0000.14%
Cowen Investment Management LLC 50,000$501,0000.11%
First Trust Capital Management L.P. 208,598$2,090,0000.10%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders